Location: Home
  • search
  • go
  • Relate News
  • 7/2/2025HanchorBio and Henlius Ink Major Licensing Deal for I/O Candidate HCB1...
  • 7/2/2025China Issues Technical Guidance for Clinical Resistance Studies of Ant...
  • 7/2/2025China to Eliminate CD Submission Requirement for Clinical Trial Databa...
  • 7/2/2025API China 2025 Ends with High Attendance and Global Industry Participa...
  • 7/2/2025Medical Advances Soar With APAC's Clinical Trial Growth (BioSpectrum)
  • 7/2/2025FDA's Crackdown and China's Dealmaking: Warning Signs or Business as U...
  • 7/1/2025China Launches Landmark Measures to Boost Innovative Drug Industry, Se...
  • 7/1/2025BeOne Launches Phase III Trial Comparing Subcutaneous and Intravenous ...
  • 7/1/2025Tracking the Crossroads of Policy, Innovation, and Global Biotech Inve...
  • 7/1/2025Mabwell Announces License Deal with Qilu for Albipagrastim alfa for I...
  • 7/1/2025Hutchmed Receives Chinese Approval for Lung Cancer Drug Combo, Trigger...
  • 7/1/2025Biological E and China's Recbio Partner to Bring HPV9 Vaccine to India...
  • 7/1/2025CDE Seeks Feedback on Draft Guidelines for Pharma Changes in Cell Ther...
  • 7/1/2025NHSA Seeks Public Input on 2025 Drug Reimbursement and Innovation List...
  • 7/1/2025Healthgen Biotech IPO Approved, First STAR Market Biopharma Case Since...
  • 7/1/2025Adagene Secures Up to $25 Million from Sanofi to Advance SAFEbody Pipe...
  • 7/1/2025Hengrui's Ivarmacitinib Approved in China for Severe Alopecia Areata
  • 7/1/2025Revolution Medicines and Summit Therapeutics Launch RAS-Targeting Comb...
  • 7/1/2025​​​​​​​Zai Lab-Backed FORTITUDE-101 Trial Hits Key Milestone in...
  • 7/1/2025China Launches New Tax Incentives to Boost Foreign Companies' Reinvest...
  • 7/1/2025China's STAR Market Approves Heyuan Biotech's IPO
  • 7/1/2025Jinhua Conba and EVA Forge Strategic Partnership to Strengthen China-M...
  • 7/1/2025Record China Pharma Monopoly Fine Sends Strong Deterrent Signal, Exper...
  • 6/30/2025BlissBio Advances Toward IPO with Focus on Next-Generation ADC Therapi...
  • 6/30/2025CTTQ's Anlotinib Wins Approval in China for First-Line Treatment of Ad...
  • 6/30/2025Cutia's Topical Finasteride Spray CU‑40102 Approved in China for Hair...
  • 6/30/2025Pfizer China's Emblaveo Cleared by NMPA for Tough Gram‑Negative Infec...
  • 6/30/2025Conjupro Files USPTO Challenge on Ascletis' U.S. Patent for GLP‑1R Ag...
  • 6/30/2025QL Biopharma's Dual GLP‑1/FGF21 Agonist ZT‑003 Gains IND Nod in U.S....
  • 6/30/2025GenFleet IPO Highlights Promising RAS-Targeted Drug Pipeline
  • Page:6/780 Total number of articles:23377: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group